logo
Diagnostics for resource-limited settings in the era of interferon-free HCV therapy
Antibody screening tests variably overestimate the prevalence of hepatitis C virus infection among HIV-infected adults in Ghana
Undetectable HCV-RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: the International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program
Changes in characteristics of hepatitis C patients seen in a liver centre in the United States during the last decade
Uptake and utilization of directly acting antiviral medications for hepatitis C infection in U.S. veterans
Decreasing prevalence of HCV coinfection in all risk groups for HIV infection between 2004 and 2011 in Spain
Long-term entecavir or tenofovir disoproxil fumarate therapy in treatment-naïve chronic hepatitis B patients in the real-world setting
Antiviral treatment discontinuation among hepatitis C-infected individuals with thrombocytopenia
Misdiagnosis of patients may be derived from the interfering factors and used cut-offs in indexes
Answer to ‘Misdiagnosis of patients may be derived from the interfering factors and used cut-offs in indexes’